Northpointe Capital’s Clorox CLX Stock Holding History

Northpointe Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-14,504	Closed	-$1.83M	–	200
2016 Q1	$1.83M	Buy	+14,504	New	+$1.84M	0.23%	157

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Analytic Investors Los Angeles, California $8.93B AUM 13.54% 1-Year Est. Return

Northpointe Capital's CLX Position: Q2 2016 in Review

Northpointe Capital sold out of Clorox (CLX) in Q2 2016, closing a stake of 14,504 shares — an estimated $1.83M sold.

Northpointe Capital first reported a position in CLX in Q1 2016 and held it in 1 quarter. The position peaked at $1.83M in Q1 2016. 843 funds tracked by Wall St. Rank hold CLX as of Q2 2016.

Northpointe Capital reported no remaining Clorox position as of Q2 2016 after selling out during the quarter.
Northpointe Capital sold 14,504 Clorox shares in Q2 2016, an estimated $1.83M.
Northpointe Capital first reported a position in Clorox in Q1 2016 and held it in 1 quarter.
Northpointe Capital's Clorox position peaked at $1.83M in Q1 2016.
843 funds tracked by Wall St. Rank held Clorox as of Q2 2016.

Based on Northpointe Capital's 13F filing for Q2 2016, filed 27 Jul 2016.